- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Ustekinumab – November 2014
Ustekinumab; 45 mg/0.5 mL injection, 1 x 0.5 mL vial; Stelara®
Last updated
20 March 2015